Last reviewed · How we verify

NCT06382961

Postoperative Dexmedetomidine in Prevention of Postoperative Delirium

Completed NA Last updated 24 May 2024
What this trial tests

NA trial testing Dexmedetomidine injection in Delirium in Old Age in 287 participants. Completed in 28 April 2024.

Timeline
11 November 2023
Primary endpoint
6 March 2024
28 April 2024

Quick facts

Lead sponsorBoston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment287
Start date11 November 2023
Primary completion6 March 2024
Estimated completion28 April 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

Who can join

65 and older, any sex, with Delirium in Old Age or Anesthesia; Adverse Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn how postoperative infusion of dexmedetomidine would influence postoperative delirium in elderly patients undergoing lung surgery. The main questions it aims to answer are : 1. Does postoperative dexmedetomidine reduce the incidence of delirium after lung surgery? 2. Does postoperative dexmedetomidine introduce other medical problems? Researchers will compare dexmedetomidine and sufentanil to see if dexmedetomidine works to reduce delirium. Participants will undergo routine postoperative care: 1. Patient-controlled self anesthesia with sufentanil only or combination of sufentanil and dexmedetomidine 2. Postoperative visit twice a day for at least seven days

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexmedetomidine injection

Trials testing the same drug.

Other recruiting trials for Delirium in Old Age

Currently open trials in the same condition.

Other Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06382961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing